BMS-914392

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Atrial Fibrillation

Phase 1

Effect of BMS-914392 on Pharmacokinetics of Metoprolol

CompletedNCT01211821

Bristol-Myers SquibbAtrial Fibrillation

Start: 2010-09-30End: 2010-11-30Updated: 2011-02-02

Phase 2

Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden

CompletedNCT01356914

Bristol-Myers SquibbAtrial Fibrillation

Start: 2011-05-31End: 2012-06-30Updated: 2015-10-12

Related Papers

First clinical trial of specific I<sub>KACh</sub>blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS 914392 in patients with paroxysmal atrial fibrillation

EP Europace2015-10-1249 citations